Concepedia

Douglas McHugh

DM

Statistics

Publications

15

Citations

1.3K

H-Index

15

Active since

1998

Affiliations

Indiana University Bloomington(Current)

Quinnipiac University

University of Aberdeen

National Cheng Kung University

Douglas McHugh is an author at Indiana University Bloomington specializing in pharmacology, cannabinoid pharmacology, and signal transduction.

ORCID

Publications per year

1998–2021

15

Publications

15

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

Douglas McHugh, Sherry S-J. Hu, Neta Rimmerman et al. · BMC Neuroscience · 2010 · 318 citations · Full text

, , +15

Δ<sup>9</sup>‐Tetrahydrocannabinol and<i>N</i>‐arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC‐1B cells

Douglas McHugh, Jeremy Page, Emily Dunn et al. · British Journal of Pharmacology · 2011 · 248 citations · Full text

, , +11

Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB1 and CB2

Douglas McHugh, Carolyn Tanner, Raphael Mechoulam et al. · Molecular Pharmacology · 2007 · 129 citations

, , +13

Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation

Siham Raboune, Jordyn Stuart, Emma Leishman et al. · Frontiers in Cellular Neuroscience · 2014 · 119 citations · Full text

, , +10

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

Rudolf Schicho, Mohammad Bashashati, Misha Bawa et al. · Inflammatory Bowel Diseases · 2010 · 108 citations · Full text

, , +15

1–5 of 15